TGFB1 and systemic sclerosis: Since the discovery of the potent profibrotic and immunomodulatory activities of transforming growth factor-β (TGF-β), this cytokine has been considered a central player in the process of fibrogenesis in systemic sclerosis (SSc) and other fibrotic diseases.